Human Research Protection Award Recipients Announced 12/5/2003
From: Preeti Deshpande of the Health Improvement Institute, 301-652-1818 BETHESDA, Md., Dec. 5 -- Winners of the 2003 Award for Excellence in Human Research Protection were announced today by Dr. Peter G. Goldschmidt, president and founder of the Health Improvement Institute. University of Texas, M.D. Anderson Cancer Center, Houston, Texas, received the Award of Excellence for their best practice, Comprehensive Clinical Research Training Program. Dr. Barry F. Brown, Ethica Clinical Research Inc, Quebec, Canada, received the Award of Excellence for lifetime achievement. Dr. Barry F. Brown has shown a life-long commitment to research ethics and has contributed towards ensuring the protection of human research subjects through his work. Awards are given for demonstrated excellence in promoting the well being of people who participate in research. The Institute has established 3 annual awards: -- Best practice that has demonstrated benefit -- given to a research institution, unit (for example, Institutional Review Board), or individual -- Innovation established through research or other report published in the last 5 years -- given to an individual (or team) who produced a significant contribution to advancing human research protection -- Lifetime achievement -- given to an individual (in academe, industry, or government) The Health Improvement Institute created this awards program. The Office for Human Research Protections of the Department of Health and Human Services is the founding sponsor of the awards program. It represents an innovative public-private partnership. Additional sponsors include Pfizer, Inc. and MCMC llc. Judges and Committee and Award Advisory Board members are volunteers. ------ The Health Improvement Institute is a non-profit 501(c)3 charitable organization dedicated to improving the quality and productivity of America's health care. The Institute conducts forums on emerging treatments and sponsors national awards recognizing excellence in health communications. The Office for Human Research Protections (OHRP) - together with the federal Food and Drug Administration -- oversees programs for the protections of human subjects at more than 4,000 HHS-funded universities, hospitals, and other medical and behavioral research institutions and private research sites in the United States and abroad. OHRP focuses on proactive education and quality improvement initiatives, together with enhanced compliance oversight and surveillance, to achieve greater effectiveness and accountability in human research protection programs. To complement its oversight role, OHRP promotes private, voluntary accreditation as a means to improve the overall quality and effectiveness of the system for protection of research participants. Pfizer Inc discovers, develops, manufactures and markets leading prescription medicines, for humans and animals, and many of the world's best-known consumer brands. Pfizer Global Research and Development, the R&D division of Pfizer Inc, is the world's largest privately funded biomedical research operation. With a 2003 budget of $7.1 billion and 15,000 researchers at sites around the world, Pfizer Global R&D has 400 potential new medicines in development for diseases including cancer, diabetes, heart disease and Alzheimer's disease. MCMC llc is the largest multi-line provider of evidence-based independent medical reviews. Each year, MCMC completes about 100,000 medical evaluations for the company's more than 600 corporate clients. The company's panel of medical specialists exceeds 5,000 credentialed practitioners and other experts. MCMC provides case reviews and examinations in all domains of medicine, for all levels of technology, for all age groups. ------ For information about the 2004 Award for Excellence in Human Research Protection, please contact the Awards Coordinator at 301-652-1818 or by email hii@mcman.com. |